A number of recent observational studies have shown that statins might be associated with a lower risk of gastric cancer. This finding is now supported by a systematic review and meta-analysis. The authors included 11 studies, covering a total of 5,581 cases of gastric cancer and showed a 32% reduction in gastric cancer risk was associated with statin use. After excluding one study that was contributing to considerable heterogeneity in their results, a significant 16% reduction was defined as a more-consistent estimate of the reduction in gastric cancer risk associated with statin use. This chemopreventative association was present in both Asian and Western populations and was dose dependent.